全文获取类型
收费全文 | 307062篇 |
免费 | 10850篇 |
国内免费 | 483篇 |
专业分类
耳鼻咽喉 | 2534篇 |
儿科学 | 10191篇 |
妇产科学 | 5598篇 |
基础医学 | 35106篇 |
口腔科学 | 4298篇 |
临床医学 | 28077篇 |
内科学 | 57696篇 |
皮肤病学 | 3007篇 |
神经病学 | 30170篇 |
特种医学 | 13490篇 |
外国民族医学 | 6篇 |
外科学 | 45701篇 |
综合类 | 3935篇 |
一般理论 | 128篇 |
预防医学 | 29706篇 |
眼科学 | 4845篇 |
药学 | 18139篇 |
中国医学 | 802篇 |
肿瘤学 | 24966篇 |
出版年
2023年 | 698篇 |
2022年 | 705篇 |
2021年 | 2890篇 |
2020年 | 1761篇 |
2019年 | 2743篇 |
2018年 | 24771篇 |
2017年 | 19387篇 |
2016年 | 21813篇 |
2015年 | 4150篇 |
2014年 | 5145篇 |
2013年 | 6735篇 |
2012年 | 15961篇 |
2011年 | 29883篇 |
2010年 | 23783篇 |
2009年 | 16075篇 |
2008年 | 27436篇 |
2007年 | 30020篇 |
2006年 | 8899篇 |
2005年 | 10270篇 |
2004年 | 11020篇 |
2003年 | 11232篇 |
2002年 | 9224篇 |
2001年 | 2323篇 |
2000年 | 2313篇 |
1999年 | 2093篇 |
1998年 | 1811篇 |
1997年 | 1545篇 |
1996年 | 1211篇 |
1995年 | 1183篇 |
1994年 | 1050篇 |
1993年 | 940篇 |
1992年 | 1347篇 |
1991年 | 1284篇 |
1990年 | 1254篇 |
1989年 | 1162篇 |
1988年 | 1010篇 |
1987年 | 942篇 |
1986年 | 934篇 |
1985年 | 953篇 |
1984年 | 827篇 |
1983年 | 744篇 |
1982年 | 757篇 |
1981年 | 609篇 |
1980年 | 580篇 |
1979年 | 607篇 |
1978年 | 477篇 |
1977年 | 435篇 |
1975年 | 380篇 |
1974年 | 439篇 |
1973年 | 392篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
2.
3.
4.
Rizzo Manglio Miguel Bluthgen Mara Virginia Recondo Gonzalo Naveira Martin Perfetti Aldo Rizzi Florencia Kuzminin Alejandro Faura Victoria Cerini Matas Videla Alejandro Silva Carlos Lupinacci Lorena Minatta Nicols 《International journal of clinical oncology / Japan Society of Clinical Oncology》2021,26(6):1057-1064
International Journal of Clinical Oncology - Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status... 相似文献
5.
6.
Emeline Colomba Patricia Pautier Fanny Pommeret Alexandra Leary 《Expert review of anticancer therapy》2019,19(6):437-446
Introduction: The landscape of poly (ADP-ribose) polymerase (PARP) inhibition in ovarian cancer is rapidly evolving and becoming increasingly complex. Ovarian cancer is leading therapeutic innovation by providing the proof of concept for DNA repair as a target. Three different PARP inhibitors have now received approvals in the US and Europe in different indications. Subtle but crucial differences can be found among the licensed indications for each PARP inhibitor in terms of histology, type of BRCA mutation (germline and/or somatic), number of prior lines of chemotherapy and whether the indication is in the treatment or maintenance settings.
Areas covered: We review the latest clinical data regarding the PARP inhibitor rucaparib in ovarian cancer, provide an update on the evolving landscape of PARP inhibition in ovarian cancer, and summarize avenues of ongoing and future research.
Expert opinion: All eligible patients should be offered a PARP inhibitor. SOLO1 trial results demonstrated an unprecedented benefit maintenance with PARP inhibitors in first line. Results from trials evaluating PARP inhibitors as maintenance in first line regardless of BRCA status and from trials evaluating combinatorial strategies are eagerly awaited. 相似文献
7.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
8.
Rebecca Martin 《Early child development and care》2019,189(4):683-696
The current study explored the influence of three methods of parental emotion discourse (structured story-telling, reminiscing, and picture book) and their relation to preschoolers’ emotion understanding. Thirty-seven families participated in the study. Analyses showed that the structured story-telling method produced more emotion words, was high in unique emotion words, and was high for both emotion labelling and explanations. All three methods showed some potential to predict preschooler’s emotion understanding. Structured story-telling was best at predicting role-taking, while reminiscing and the picture book both were better at predicting situation knowledge. Additional studies are needed to further explore the influence of different methods of assessing emotion discourse to enhance validity and reliability of research in this field. 相似文献
9.
Martin R. Späth Malte P. Bartram Nicolàs Palacio-Escat K. Johanna R. Hoyer Cedric Debes Fatih Demir Christina B. Schroeter Amrei M. Mandel Franziska Grundmann Giuliano Ciarimboli Andreas Beyer Jayachandran N. Kizhakkedathu Susanne Brodesser Heike Göbel Jan U. Becker Thomas Benzing Bernhard Schermer Martin Höhne Markus M. Rinschen 《Kidney international》2019,95(2):333-349
10.
Notfall + Rettungsmedizin - 相似文献